Literature DB >> 27542589

An update on the role of irreversible electroporation in locally advanced pancreatic adenocarcinoma.

Robert C G Martin1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27542589      PMCID： PMC5061020          DOI： 10.1016/j.hpb.2016.07.007

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  17 in total

1.  Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

Review 2.  Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review.

Authors:  Samira Fegrachi; Marc G Besselink; Hjalmar C van Santvoort; Richard van Hillegersberg; Izaak Quintus Molenaar
Journal:  HPB (Oxford)       Date:  2013-04-18       Impact factor: 3.647

3.  Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.

Authors:  Matthew Bower; Leslie Sherwood; Yan Li; Robert Martin
Journal:  J Surg Oncol       Date:  2011-02-28       Impact factor: 3.454

4.  Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.

Authors:  David Kwon; Kelli McFarland; Vic Velanovich; Robert C G Martin
Journal:  Surgery       Date:  2014-10       Impact factor: 3.982

5.  Irreversible electroporation of locally advanced pancreatic neck/body adenocarcinoma.

Authors:  Robert C G Martin
Journal:  J Gastrointest Oncol       Date:  2015-06

6.  Irreversible electroporation of locally advanced pancreatic head adenocarcinoma.

Authors:  Robert C G Martin
Journal:  J Gastrointest Surg       Date:  2013-08-09       Impact factor: 3.452

7.  Low-energy DC current ablation in a mouse tumor model.

Authors:  Prejesh Philips; Yan Li; Robert C G Martin
Journal:  Methods Mol Biol       Date:  2014

8.  Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  Ann Surg Oncol       Date:  2012-11-06       Impact factor: 5.344

9.  Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Authors:  Joseph M Herman; Daniel T Chang; Karyn A Goodman; Avani S Dholakia; Siva P Raman; Amy Hacker-Prietz; Christine A Iacobuzio-Donahue; Mary E Griffith; Timothy M Pawlik; Jonathan S Pai; Eileen O'Reilly; George A Fisher; Aaron T Wild; Lauren M Rosati; Lei Zheng; Christopher L Wolfgang; Daniel A Laheru; Laurie A Columbo; Elizabeth A Sugar; Albert C Koong
Journal:  Cancer       Date:  2014-12-23       Impact factor: 6.860

10.  Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated.

Authors:  Prejesh Philips; David Hays; Robert C G Martin
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240
View more
  2 in total

1.  Case report: Irreversible electroporation for locally advanced pancreatic cancer.

Authors:  Sonia Orcutt; Bela Kis; Mokenge Malafa
Journal:  Int J Surg Case Rep       Date:  2017-09-01

2.  Irreversible electroporation enhances immunotherapeutic effect in the off-target tumor in a murine model of orthotopic HCC.

Authors:  Xiaoju Shi; Conor O'Neill; Xingtong Wang; Yujia Chen; Youxi Yu; Min Tan; Guoyue Lv; Yan Li; Robert C Martin
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.